Item(by='acqq', descendants=None, kids=[25279761, 25285605], score=None, time=1606933783, title=None, item_type='comment', url=None, parent=25279442, text='No, at the moment &quot;the main purpose of a vaccine&quot; is still <i>not</i> &quot;herd immunity&quot; <i>at all</i>. The Phase 3 trial protocols measured and presented the &quot;efficacy&quot; which is defined as the reducing the chance of the vaccinated getting sick -- that is, merely reducing <i>the severity of disease</i> among those who were vaccinated.<p><a href="https:&#x2F;&#x2F;www.medscape.com&#x2F;viewarticle&#x2F;941030?src=soc_tw_201118_mscpedt_news_mdscp_vaccine&amp;faf=1" rel="nofollow">https:&#x2F;&#x2F;www.medscape.com&#x2F;viewarticle&#x2F;941030?src=soc_tw_20111...</a><p>&quot;In an ideal world, a vaccine would prevent infection entirely and, it follows, also prevent disease and severe disease. But <i>this may be hard to achieve for a respiratory virus vaccine.</i> Animal challenge data suggest that <i>vaccinated animals may still be infected even if they don&#x27;t experience symptoms</i>. A vaccine that is able to reduce the severity of disease, even if it cannot prevent infection entirely, would obviously still have enormous public health value. Therefore, this is what trials target as their primary aim.&quot;<p>Not all vaccines are the same.<p>For mumps, totally different kind of disease, to prevent an outbreak, there was a following calculation:<p><a href="https:&#x2F;&#x2F;vector.childrenshospital.org&#x2F;2017&#x2F;03&#x2F;social-media-mumps-herd-immunity&#x2F;" rel="nofollow">https:&#x2F;&#x2F;vector.childrenshospital.org&#x2F;2017&#x2F;03&#x2F;social-media-mu...</a><p>&quot;since one in 10 vaccinated people are still susceptible to mumps, an <i>overall vaccination rate of 96 percent is needed</i> to prevent an outbreak&quot;<p>For Covid-19, to note from the first source again:<p>&quot;A vaccine that is able to <i>reduce the severity of disease</i>, even if it cannot prevent infection entirely, would obviously still have enormous public health value. Therefore, this is what trials target as their primary aim.&quot;')